Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Functional heterogeneity of human tissue-resident memory T cells based on dye efflux capacities
Brahma V. Kumar, Radomir Kratchmarov, Michelle Miron, Dustin J. Carpenter, Takashi Senda, Harvey Lerner, Amy Friedman, Steven L. Reiner, Donna L. Farber
Brahma V. Kumar, Radomir Kratchmarov, Michelle Miron, Dustin J. Carpenter, Takashi Senda, Harvey Lerner, Amy Friedman, Steven L. Reiner, Donna L. Farber
View: Text | PDF
Research Article Immunology

Functional heterogeneity of human tissue-resident memory T cells based on dye efflux capacities

  • Text
  • PDF
Abstract

Tissue-resident memory T cells (TRMs) accelerate pathogen clearance through rapid and enhanced functional responses in situ. TRMs are prevalent in diverse anatomic sites throughout the human lifespan, yet their phenotypic and functional diversity has not been fully described. Here, we identify subpopulations of human TRMs based on the ability to efflux fluorescent dyes [efflux(+) TRMs] located within mucosal and lymphoid sites with distinct transcriptional profiles, turnover, and functional capacities. Compared with efflux(–) TRMs, efflux(+) TRMs showed transcriptional and phenotypic features of quiescence including reduced turnover, decreased expression of exhaustion markers, and increased proliferative capacity and signaling in response to homeostatic cytokines. Moreover, upon activation, efflux(+) TRMs secreted lower levels of inflammatory cytokines such as IFN-γ and IL-2 and underwent reduced degranulation. Interestingly, analysis of TRM subsets following activation revealed that both efflux(+) and efflux(–) TRMs undergo extensive transcriptional changes following TCR ligation but retain core TRM transcriptional properties including retention markers, suggesting that TRMs carry out effector function in situ. Overall, our results suggest a model for tissue-resident immunity wherein heterogeneous subsets have differential capacities for longevity and effector function.

Authors

Brahma V. Kumar, Radomir Kratchmarov, Michelle Miron, Dustin J. Carpenter, Takashi Senda, Harvey Lerner, Amy Friedman, Steven L. Reiner, Donna L. Farber

×

Figure 2

Efflux(+) memory CD8+ T cells are enriched in the TRM fraction across human tissues.

Options: View larger image (or click on image) Download as PowerPoint
Efflux(+) memory CD8+ T cells are enriched in the TRM fraction across hu...
(A) Upper: CD69 expression by efflux(+) (Mitolo) and efflux(–) (Mitohi) subsets of memory CD8+ T cells in the indicated tissues. Lower: Compiled frequency of efflux(+) cells within the CD69+ (TRM-enriched) and CD69– subsets of memory CD8+ T cells in each tissue site, with each line connecting subsets from 1 individual donor (spleen, 17 donors; bone marrow, 7 donors; lung, 6 donors). (B) Frequency of TRMs that are efflux(+) in each tissue site, with bars showing mean ± SEM and individual donors represented by single dots. (C) Upper: CD103 expression by efflux(+) and efflux(–) TRMs in spleen and lung. Lower: Compiled frequency of CD103 expression among efflux(+) and efflux(–) TRMs in the spleen (n = 10) and lung (n = 6), with each line connecting subsets within individual donors. (D) Upper: Expression of CD49a and CD101 among efflux(+) and efflux(–) TRMs (CD69+) from the spleen of a representative donor. Lower: Compiled frequency of CD49a- and CD101-expressing cells within efflux(+) and efflux(–) splenic TRMs (n = 6). For all panels, *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001 by paired t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts